2021 ICD-10-CM Diagnosis Code E27.5

Adrenomedullary hyperfunction

    2016 2017 2018 2019 2020 2021 Billable/Specific Code
  • E27.5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2021 edition of ICD-10-CM E27.5 became effective on October 1, 2020.
  • This is the American ICD-10-CM version of E27.5 - other international versions of ICD-10 E27.5 may differ.
Applicable To
  • Adrenomedullary hyperplasia
  • Catecholamine hypersecretion
The following code(s) above E27.5 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to E27.5:
  • E00-E89
    2021 ICD-10-CM Range E00-E89

    Endocrine, nutritional and metabolic diseases

    Note
    • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
    Type 1 Excludes
    • transitory endocrine and metabolic disorders specific to newborn (P70-P74)
    Endocrine, nutritional and metabolic diseases
  • E20-E35
    2021 ICD-10-CM Range E20-E35

    Disorders of other endocrine glands

    Type 1 Excludes
    Disorders of other endocrine glands
Approximate Synonyms
  • Medulloadrenal hyperfunction
ICD-10-CM E27.5 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):
  • 643 Endocrine disorders with mcc
  • 644 Endocrine disorders with cc
  • 645 Endocrine disorders without cc/mcc

Convert E27.5 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change

Diagnosis Index entries containing back-references to E27.5:

ICD-10-CM Codes Adjacent To E27.5
E26.89 Other hyperaldosteronism
E26.9 Hyperaldosteronism, unspecified
E27 Other disorders of adrenal gland
E27.0 Other adrenocortical overactivity
E27.1 Primary adrenocortical insufficiency
E27.2 Addisonian crisis
E27.3 Drug-induced adrenocortical insufficiency
E27.4 Other and unspecified adrenocortical insufficiency
E27.40 Unspecified adrenocortical insufficiency
E27.49 Other adrenocortical insufficiency
E27.5 Adrenomedullary hyperfunction
E27.8 Other specified disorders of adrenal gland
E27.9 Disorder of adrenal gland, unspecified
E28 Ovarian dysfunction
E28.0 Estrogen excess
E28.1 Androgen excess
E28.2 Polycystic ovarian syndrome
E28.3 Primary ovarian failure
E28.31 Premature menopause
E28.310 Symptomatic premature menopause
E28.319 Asymptomatic premature menopause

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.